Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810

01 Oct 2016
0

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810

Tags

Share this

Related Posts

Khunnawutmanotham, N.; Laongthipparos, C.; Saparpakorn, P.; Chimnoi, N.; Techasakul, S. Synthesis of 3-Aminocoumarin-N-benzylpyridinium Conjugates with Nanomolar Inhibitory Activity Against acetylcholinesterase. Beilstein J. Org. Chem. 2018, 14, 2545-2452.
Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New